A 32-year-old woman is evaluated for anticoagulation management after an uncomplicated vaginal delivery of a healthy newborn. She was diagnosed with a bilateral pulmonary embolism at 25 weeks’ gestation and was treated with therapeutic low-molecular-weight heparin (LMWH). The LMWH was discontinued at the onset of labor and was restarted 6 hours after delivery. Medical history is otherwise unremarkable, and her only medication is full-dose LMWH.
Anticoagulation for 3 months is planned. The patient wishes to breastfeed her newborn.
Which of the following is the most appropriate anticoagulation option for this patient?
A: Apixaban
B: Dabigatran
C: Fondaparinux
D: Rivaroxaban
E: Warfarin
No comments:
Post a Comment